143 related articles for article (PubMed ID: 10192846)
1. Protein aggregation complicates the development of baculovirus-expressed African horsesickness virus serotype 5 VP2 subunit vaccines.
du Plessis M; Cloete M; Aitchison H; Van Dijk AA
Onderstepoort J Vet Res; 1998 Dec; 65(4):321-9. PubMed ID: 10192846
[TBL] [Abstract][Full Text] [Related]
2. Expression and characterization of the two outer capsid proteins of African horsesickness virus: the role of VP2 in virus neutralization.
Martinez-Torrecuadrada JL; Iwata H; Venteo A; Casal I; Roy P
Virology; 1994 Jul; 202(1):348-59. PubMed ID: 8009847
[TBL] [Abstract][Full Text] [Related]
3. Immunization with VP2 is sufficient for protection against lethal challenge with African horsesickness virus Type 4.
Stone-Marschat MA; Moss SR; Burrage TG; Barber ML; Roy P; Laegreid WW
Virology; 1996 Jun; 220(1):219-22. PubMed ID: 8659117
[TBL] [Abstract][Full Text] [Related]
4. Recombinant baculovirus-synthesized African horsesickness virus (AHSV) outer-capsid protein VP2 provides protection against virulent AHSV challenge.
Roy P; Bishop DH; Howard S; Aitchison H; Erasmus B
J Gen Virol; 1996 Sep; 77 ( Pt 9)():2053-7. PubMed ID: 8811002
[TBL] [Abstract][Full Text] [Related]
5. Full protection against African horsesickness (AHS) in horses induced by baculovirus-derived AHS virus serotype 4 VP2, VP5 and VP7.
Martínez-Torrecuadrada JL; Díaz-Laviada M; Roy P; Sánchez C; Vela C; Sánchez-Vizcaíno JM; Casal JI
J Gen Virol; 1996 Jun; 77 ( Pt 6)():1211-21. PubMed ID: 8683209
[TBL] [Abstract][Full Text] [Related]
6. Protective immunization of horses with a recombinant canarypox virus vectored vaccine co-expressing genes encoding the outer capsid proteins of African horse sickness virus.
Guthrie AJ; Quan M; Lourens CW; Audonnet JC; Minke JM; Yao J; He L; Nordgren R; Gardner IA; Maclachlan NJ
Vaccine; 2009 Jul; 27(33):4434-8. PubMed ID: 19490959
[TBL] [Abstract][Full Text] [Related]
7. The protective efficacy of a recombinant VP2-based African horsesickness subunit vaccine candidate is determined by adjuvant.
Scanlen M; Paweska JT; Verschoor JA; van Dijk AA
Vaccine; 2002 Jan; 20(7-8):1079-88. PubMed ID: 11803068
[TBL] [Abstract][Full Text] [Related]
8. Preparation of recombinant African horse sickness virus VP7 antigen via a simple method and validation of a VP7-based indirect ELISA for the detection of group-specific IgG antibodies in horse sera.
Maree S; Paweska JT
J Virol Methods; 2005 Apr; 125(1):55-65. PubMed ID: 15737417
[TBL] [Abstract][Full Text] [Related]
9. A single dose of African horse sickness virus (AHSV) VP2 based vaccines provides complete clinical protection in a mouse model.
Aksular M; Calvo-Pinilla E; Marín-López A; Ortego J; Chambers AC; King LA; Castillo-Olivares J
Vaccine; 2018 Nov; 36(46):7003-7010. PubMed ID: 30309744
[TBL] [Abstract][Full Text] [Related]
10. Vaccination with recombinant Modified Vaccinia Ankara (MVA) viruses expressing single African horse sickness virus VP2 antigens induced cross-reactive virus neutralising antibodies (VNAb) in horses when administered in combination.
Manning NM; Bachanek-Bankowska K; Mertens PPC; Castillo-Olivares J
Vaccine; 2017 Oct; 35(44):6024-6029. PubMed ID: 28438410
[TBL] [Abstract][Full Text] [Related]
11. An African horse sickness virus serotype 4 recombinant canarypox virus vaccine elicits specific cell-mediated immune responses in horses.
El Garch H; Crafford JE; Amouyal P; Durand PY; Edlund Toulemonde C; Lemaitre L; Cozette V; Guthrie A; Minke JM
Vet Immunol Immunopathol; 2012 Sep; 149(1-2):76-85. PubMed ID: 22763149
[TBL] [Abstract][Full Text] [Related]
12. A first full outer capsid protein sequence data-set in the Orbivirus genus (family Reoviridae): cloning, sequencing, expression and analysis of a complete set of full-length outer capsid VP2 genes of the nine African horsesickness virus serotypes.
Potgieter AC; Cloete M; Pretorius PJ; van Dijk AA
J Gen Virol; 2003 May; 84(Pt 5):1317-1326. PubMed ID: 12692299
[TBL] [Abstract][Full Text] [Related]
13. Immunogenicity of recombinant VP2 proteins of all nine serotypes of African horse sickness virus.
Kanai Y; van Rijn PA; Maris-Veldhuis M; Kaname Y; Athmaram TN; Roy P
Vaccine; 2014 Sep; 32(39):4932-7. PubMed ID: 25045805
[TBL] [Abstract][Full Text] [Related]
14. In vivo cross-protection to African horse sickness Serotypes 5 and 9 after vaccination with Serotypes 8 and 6.
von Teichman BF; Dungu B; Smit TK
Vaccine; 2010 Sep; 28(39):6505-17. PubMed ID: 20638456
[TBL] [Abstract][Full Text] [Related]
15. Identification of a linear neutralization domain in the protein VP2 of African horse sickness virus.
Martínez-Torrecuadrada JL; Casal JI
Virology; 1995 Jul; 210(2):391-9. PubMed ID: 7542417
[TBL] [Abstract][Full Text] [Related]
16. Cloning, sequencing and expression of the gene that encodes the major neutralisation-specific antigen of African horsesickness virus serotype 9.
Venter M; Napier G; Huismans H
J Virol Methods; 2000 Apr; 86(1):41-53. PubMed ID: 10713375
[TBL] [Abstract][Full Text] [Related]
17. Cloning, characterization and expression of the gene that encodes the major neutralization-specific antigen of African horsesickness virus serotype 3.
Vreede FT; Huismans H
J Gen Virol; 1994 Dec; 75 ( Pt 12)():3629-33. PubMed ID: 7996157
[TBL] [Abstract][Full Text] [Related]
18. Multiple large foreign protein expression by a single recombinant baculovirus: a system for production of multivalent vaccines.
Kanai Y; Athmaram TN; Stewart M; Roy P
Protein Expr Purif; 2013 Sep; 91(1):77-84. PubMed ID: 23872366
[TBL] [Abstract][Full Text] [Related]
19. Neutralizing epitopes of African horsesickness virus serotype 4 are located on VP2.
Burrage TG; Trevejo R; Stone-Marschat M; Laegreid WW
Virology; 1993 Oct; 196(2):799-803. PubMed ID: 7690505
[TBL] [Abstract][Full Text] [Related]
20. Vaccination of mice with a modified Vaccinia Ankara (MVA) virus expressing the African horse sickness virus (AHSV) capsid protein VP2 induces virus neutralising antibodies that confer protection against AHSV upon passive immunisation.
Calvo-Pinilla E; de la Poza F; Gubbins S; Mertens PP; Ortego J; Castillo-Olivares J
Virus Res; 2014 Feb; 180():23-30. PubMed ID: 24333835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
